D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $20.3M | 0.03% |
+184,285
| New | +$19.9M |
|
|
PE
702
DELISTED
PARSLEY ENERGY INC
PE
| $20.3M | 0.03% |
1,050,685
-1,039,138
| -50% | -$19.1M |
|
|
WMGI
703
DELISTED
Wright Medical Group Inc
WMGI
| $20.3M | 0.03% |
644,751
+213,792
| +50% | +$6.49M |
|
|
PDCO
704
DELISTED
Patterson Companies, Inc.
PDCO
| $20.3M | 0.03% |
926,902
+310,513
| +50% | +$6.88M |
|
|
GWPH
705
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $20.2M | 0.03% |
119,756
+97,525
| +439% | +$14.5M |
|
706
Nutanix
NTNX
$14.9B
| $20.2M | 0.03% |
534,309
-2,518,657
| -82% | -$115M |
|
707
PUT
Palo Alto Networks
PANW
$264B
| $20.1M | 0.03% |
497,400
-37,800
| -7% | -$1.4M |
|
708
Usana Health Sciences
USNA
$394M
| $20.1M | 0.03% |
240,047
+126,466
| +111% | +$13.2M |
|
709
PUT
Marathon Petroleum
MPC
$90.3B
| $20M | 0.03% |
334,800
-56,400
| -14% | -$3.55M |
|
|
SFIX
710
Stitch Fix
SFIX
$478M
| $20M | 0.03% |
+708,964
| New | +$17.6M |
|
711
Unum
UNM
$13.8B
| $20M | 0.03% |
591,064
+524,788
| +792% | +$18.3M |
|
712
Pan American Silver
PAAS
$18.6B
| $20M | 0.03% |
1,506,075
+1,466,408
| +3,697% | +$20.5M |
|
|
PRSP
713
DELISTED
Perspecta Inc. Common Stock
PRSP
| $20M | 0.03% |
986,924
+136,691
| +16% | +$2.75M |
|
714
Deluxe
DLX
$1.19B
| $19.9M | 0.03% |
454,366
+185,835
| +69% | +$8.34M |
|
715
OraSure Technologies
OSUR
$273M
| $19.8M | 0.03% |
1,778,157
+920,123
| +107% | +$10.7M |
|
716
American Financial Group
AFG
$11.9B
| $19.8M | 0.03% |
205,908
+46,859
| +29% | +$4.49M |
|
|
LTRPA
717
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $19.7M | 0.03% |
1,391,266
-256,952
| -16% | -$4.05M |
|
718
PUT
eBay
EBAY
$48.6B
| $19.6M | 0.03% |
527,300
-148,900
| -22% | -$5.17M |
|
719
PUT
Chevron
CVX
$388B
| $19.6M | 0.03% |
158,800
-215,100
| -58% | -$25.4M |
|
720
SM Energy
SM
$7.96B
| $19.5M | 0.03% |
1,115,736
-179,125
| -14% | -$3.18M |
|
721
Travere Therapeutics
TVTX
$5.33B
| $19.4M | 0.03% |
858,589
+81,069
| +10% | +$1.79M |
|
|
PINC
722
DELISTED
Premier
PINC
| $19.4M | 0.03% |
561,535
+300,748
| +115% | +$11.1M |
|
723
Perrigo
PRGO
$1.4B
| $19.3M | 0.02% |
400,788
-17,128
| -4% | -$802K |
|
724
Louisiana-Pacific
LPX
$5.2B
| $19.3M | 0.02% |
791,673
+190,690
| +32% | +$4.66M |
|
725
Puma Biotechnology
PBYI
$406M
| $19.2M | 0.02% |
495,226
+425,991
| +615% | +$13M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.